| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 03/02/2005 | EP1509501A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/02/2005 | EP1509499A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases |
| 03/02/2005 | EP1509224A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia |
| 03/02/2005 | EP1509213A2 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/02/2005 | EP1278741B1 Muscarinic agonists |
| 03/02/2005 | EP0871448B1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase |
| 03/02/2005 | CN1589270A Indole-2-formamide compounds as factor Xa inhibitors |
| 03/02/2005 | CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/02/2005 | CN1191251C Intermediate for preparing cyclopentane formamide compound and its preparation method |
| 03/02/2005 | CN1191250C Process for synthesizing sertaconazole nitrate |
| 03/02/2005 | CN1191249C Quinoline and quinazoline compound for treating benign prostatic hyperplasia specially |
| 03/02/2005 | CN1191239C Pyrazole derivatives for the treatment of viral diseases |
| 03/02/2005 | CN1191233C N-substituted nitrogen heterocyclic compound |
| 03/02/2005 | CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 03/01/2005 | US6861530 Piperidine derivatives |
| 03/01/2005 | US6861446 C7 heterosubstituted acetate taxane compositions |
| 03/01/2005 | US6861440 Antidiabetic agents |
| 03/01/2005 | US6861432 Piperazine derivatives that destabilize androgen receptors |
| 03/01/2005 | US6861424 A piperazine compound as antithrombotic agent |
| 03/01/2005 | CA2289221C Labeled reagents for use in immunoassays and fluorescent compounds and complexes used therein |
| 03/01/2005 | CA2138287C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/24/2005 | WO2005016919A1 Aminopyrones and their use as atm inhibitors |
| 02/24/2005 | WO2005016914A1 Chemical compounds |
| 02/24/2005 | WO2005016911A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | WO2005016910A1 Pyridyltetrahydropyridines, pyridylpiperidines, and process for the production of both |
| 02/24/2005 | WO2005016909A1 Substituted thiophenes and uses thereof |
| 02/24/2005 | WO2005016892A1 Gabanergic modulators |
| 02/24/2005 | WO2005016891A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 02/24/2005 | WO2005016883A2 Acrylamide derivatives as vla-1 integrin antagonists and uses thereof |
| 02/24/2005 | WO2005016882A1 Monomers, oligomers and polymers of 2-functionalized and 2,7-difunctionalized carbazoles |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005005393A3 Cck-1 receptor modulators |
| 02/24/2005 | WO2004096235A8 Anti-cancer phosphonate analogs |
| 02/24/2005 | WO2004093789A3 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 02/24/2005 | US20050043545 4-(5-Membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 02/24/2005 | US20050043411 Process for preparing homophthalate derivatives |
| 02/24/2005 | US20050043397 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/24/2005 | US20050043393 Antilipemic agents |
| 02/24/2005 | US20050043390 Viricides against herpes virus |
| 02/24/2005 | US20050043388 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 02/24/2005 | US20050043366 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage |
| 02/24/2005 | US20050043341 For stimulation of reverse cholesterol transport, lowering low density lipoproteins in blood; for treatment of hypolipoproteinaemia, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, arteriosclerosis adiposity and obesity stroke or Alzheimer's disease |
| 02/24/2005 | US20050043337 Selective beta3 adrenergic agonists |
| 02/24/2005 | US20050043336 Quinazoline derivatives as antitumor agents |
| 02/24/2005 | US20050043326 Compounds |
| 02/24/2005 | US20050043315 Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them |
| 02/24/2005 | US20050043313 1-(phenylaminocarbonylmethyl)-3-alkylamino-5,6-disubstituted-2-pyazinones; serine protease inhibitors; anticoagulants; coronary artery and cerebrovascular diseases |
| 02/24/2005 | US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis |
| 02/24/2005 | US20050043302 New indole derivatives as factor Xa inhibitors |
| 02/24/2005 | US20050043299 Inhibitors of dipeptidyl peptidase iv |
| 02/24/2005 | US20050043292 eg S)-[5-amino-6-oxo-6-(3,3,4,4-tetrafluoro-pyrrolidin-1-yl)-hexyl-carbamic acid benzylester; Type 2 diabetes, metabolic syndrome (syndrome X or insulin resistance syndrome), hyperglycemia, impaired glucose tolerance, glucosuria, metabolic acidosis, arthritis, cataracts, diabetic neuropathy |
| 02/24/2005 | US20050043290 for treating neurodegenerative disease such as Alzheimer's disease |
| 02/24/2005 | DE102004010545A1 Pyrazoline Pyrazolines |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2535652A1 Substituted thiophenes and uses thereof |
| 02/24/2005 | CA2535619A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | CA2535497A1 Monomers, oligomers and polymers of 2-functionalized and 2,7-difunctionalized carbazoles |
| 02/24/2005 | CA2535406A1 Gabanergic modulators |
| 02/24/2005 | CA2534300A1 Aminopyrones and their use as atm inhibitors |
| 02/23/2005 | EP1507776A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 02/23/2005 | EP1507767A1 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2b and alpha-2c adrenergic receptors |
| 02/23/2005 | EP1507761A1 Pyridine carboxamide derivatives and their use as pesticides |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP1286986B1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 02/23/2005 | EP1177177B1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
| 02/23/2005 | EP1140845B1 Susbstituted pyridine herbicides |
| 02/23/2005 | EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 02/23/2005 | EP0947507B1 Novel tetrahydrobenzindolone derivatives |
| 02/23/2005 | EP0942652B1 Substituted thienyl(amino)sulphonyl(thio)ureas as herbicides |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 02/23/2005 | CN1585757A Oligopeptides and compositions containing them as cathepsin S inhibitors |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1585754A Quinazoline derivatives as antitumor agents |
| 02/23/2005 | CN1585752A 4, 4-difluoro-1, 2, 3, 4-tetrahydro-5H-1-benzazepine derivatives or salts thereof |
| 02/23/2005 | CN1585751A 喹啉化合物 Quinoline compound |
| 02/23/2005 | CN1585749A Cannabinoid receptor ligands |
| 02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
| 02/23/2005 | CN1190424C Quinoline-containing Alpha-ketoamide cysteine and serine protease inhibitors |
| 02/22/2005 | US6858741 Use as pesticides and herbicides |
| 02/22/2005 | US6858740 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 02/22/2005 | US6858739 Indole and benzimidazole 15-lipoxygenase inhibitors |
| 02/22/2005 | US6858733 Compounds for generating chemiluminescence with a peroxidase |
| 02/22/2005 | US6858644 Use as anti-tumor agents; examples of solvents are N-methyl-2-pyrrolidone and acetonitrile |
| 02/22/2005 | US6858638 Substituted indazoles, compositions containing them, method of production and use |
| 02/22/2005 | US6858630 Administering substituted naphthimidazole derivative for therapy of thrombocytopenia |
| 02/22/2005 | US6858628 Substituted cyclic amine metalloprotease inhibitors |
| 02/22/2005 | US6858627 For therapy of inflammatory, allergic, or proliferative conditions |
| 02/22/2005 | US6858626 Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 02/22/2005 | US6858611 Antiarrhythmia agents; cardiovascular disorders |
| 02/22/2005 | US6858610 Autoimmune disease; antiinflammatory agents |
| 02/22/2005 | US6858609 Substituted diamino-1,3,5-triazine derivatives |
| 02/22/2005 | US6858603 Acetindine derivatives, their preparation and medicaments containing them |
| 02/22/2005 | US6858594 Compounds and methods for treating urinary incontinence |
| 02/22/2005 | US6858073 Transition metal or silicon matrix in which particles of an organic pigment are homogeneously embedded or crosslinked; 3-methylidene-2,3-dihydro-indol-2-ones, quinacridone, indigo, diketopyrrolopyrrole, anthraquinone, perylene; thermostable |
| 02/22/2005 | CA2289220C Labeled reagents for use in immunoassays and fluorescent compounds and complexes used therein |
| 02/22/2005 | CA2218493C Benzimidazole compounds and their use as modulators of the gabaa receptor complex |
| 02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 02/17/2005 | WO2005014588A1 Substituted thienyl-hydroxamic acids having histone deacetylase activity |